As on Thursday, GeneDx Holdings Corp (NASDAQ: WGS) got off with the flyer as it spiked 3.88% to $72.07, before settling in for the price of $69.38 at the close. Taking a more long-term approach, WGS posted a 52-week range of $1.29-$89.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 5.08% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 93.74%. This publicly-traded company’s shares outstanding now amounts to $25.98 million, simultaneously with a float of $21.35 million. The organization now has a market capitalization sitting at $1.98 billion. At the time of writing, stock’s 50-day Moving Average stood at $58.79, while the 200-day Moving Average is $30.48.
GeneDx Holdings Corp (WGS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Health Information Services industry. GeneDx Holdings Corp’s current insider ownership accounts for 22.28%, in contrast to 66.98% institutional ownership. According to the most recent insider trade that took place on Nov 19 ’24, this organization’s Director sold 31,510 shares at the rate of 71.28, making the entire transaction reach 2,246,130 in total value, affecting insider ownership by 15,490. Preceding that transaction, on Nov 20 ’24, Company’s Director sold 15,490 for 69.13, making the whole transaction’s value amount to 1,070,749. This particular insider is now the holder of 0 in total.
GeneDx Holdings Corp (WGS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.
GeneDx Holdings Corp’s EPS increase for this current 12-month fiscal period is 93.74% and is forecasted to reach 0.49 in the upcoming year.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Let’s observe the current performance indicators for GeneDx Holdings Corp (WGS). It’s Quick Ratio in the last reported quarter now stands at 2.27. The Stock has managed to achieve an average true range (ATR) of 6.20. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.41.
In the same vein, WGS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.17, a figure that is expected to reach 0.11 in the next quarter, and analysts are predicting that it will be 0.49 at the market close of one year from today.
Technical Analysis of GeneDx Holdings Corp (WGS)
Through scrutinizing the latest numbers posted by the [GeneDx Holdings Corp, WGS], it can be observed that its last 5-days Average volume of 0.58 million was better the volume of 0.45 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 28.05% While, its Average True Range was 6.50.
Raw Stochastic average of GeneDx Holdings Corp (WGS) in the period of the previous 100 days is set at 73.29%, which indicates a major rise in contrast to 35.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 61.65% that was lower than 94.71% volatility it exhibited in the past 100-days period.
